TR200003666T2 - Akut bir astım vakasının önlenmesi , tedavisi için formoterol - Google Patents
Akut bir astım vakasının önlenmesi , tedavisi için formoterolInfo
- Publication number
- TR200003666T2 TR200003666T2 TR2000/03666T TR200003666T TR200003666T2 TR 200003666 T2 TR200003666 T2 TR 200003666T2 TR 2000/03666 T TR2000/03666 T TR 2000/03666T TR 200003666 T TR200003666 T TR 200003666T TR 200003666 T2 TR200003666 T2 TR 200003666T2
- Authority
- TR
- Turkey
- Prior art keywords
- asthma
- prevention
- treatment
- formoterol
- acute
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut bulus akut bir astim vakasinin ve/veya da zaman zaman ortaya çikan astimin ve/ya da kronik astim vakalarinin önlenmesinde ya da tedavisinde, ya da semptomatik rahatlatmanin gerekli oldugu durumlarda kullanilmasi amaçlanan bir ilacin üretilmesi için; (a) birinci aktif madde olarak formoterol'ün ya da bunun farmasötik olarak uygun olan bir tuzunun ya da bu gibi bir tuzun eriyiginin; ve (b) ikinci aktif madde olarak budesonidin karisimindan olusan bir kompozisyonun kullanilmasi ile ilgilidir. Bulus ayrica akut bir astim vakasinin ve/ya da zaman zaman ortaya çikan astimin ve/ya da kronik astim vakalarinin önlenmesi ya da tedavisi için yukarida açiklanmis olan birinci ve ikinci aktif maddeleri içeren bir kompozisyonun solunum vasitasiyla uygulandigi bir yöntemle de ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802073A SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200003666T2 true TR200003666T2 (tr) | 2001-06-21 |
Family
ID=20411658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/03666T TR200003666T2 (tr) | 1998-06-11 | 1999-06-10 | Akut bir astım vakasının önlenmesi , tedavisi için formoterol |
Country Status (35)
Country | Link |
---|---|
US (2) | US20010049396A1 (tr) |
EP (3) | EP1316311A1 (tr) |
JP (1) | JP2002517450A (tr) |
KR (1) | KR20010052721A (tr) |
CN (1) | CN100389771C (tr) |
AR (1) | AR018410A1 (tr) |
AT (1) | ATE389409T1 (tr) |
AU (1) | AU771715B2 (tr) |
BR (1) | BR9911073A (tr) |
CA (1) | CA2334411C (tr) |
CY (1) | CY1110376T1 (tr) |
CZ (1) | CZ300874B6 (tr) |
DE (1) | DE69938390T2 (tr) |
DK (1) | DK1085877T3 (tr) |
EE (1) | EE05661B1 (tr) |
ES (1) | ES2302384T3 (tr) |
HK (1) | HK1035145A1 (tr) |
HU (1) | HUP0103108A3 (tr) |
ID (1) | ID27937A (tr) |
IL (2) | IL139921A0 (tr) |
IS (1) | IS5752A (tr) |
MY (1) | MY129281A (tr) |
NO (3) | NO20006253L (tr) |
NZ (1) | NZ536279A (tr) |
PL (1) | PL344665A1 (tr) |
PT (1) | PT1085877E (tr) |
RU (1) | RU2222332C2 (tr) |
SA (1) | SA99200234B1 (tr) |
SE (1) | SE9802073D0 (tr) |
SK (1) | SK286252B6 (tr) |
TR (1) | TR200003666T2 (tr) |
TW (1) | TWI252756B (tr) |
UA (1) | UA87956C2 (tr) |
WO (1) | WO1999064014A1 (tr) |
ZA (1) | ZA200006943B (tr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
GB0012260D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
GB0012261D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel process |
ME00220B (me) | 2000-05-22 | 2010-10-10 | Chiesi Farm Spa | Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom |
SI1273292T1 (en) | 2001-07-02 | 2004-12-31 | Chiesi Farmaceutici S.P.A. | Optimised formulation of tobramycin for aerosolization |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
ATE401058T1 (de) * | 2001-11-01 | 2008-08-15 | Nektar Therapeutics | Sprühtrocknungsverfahren |
FI20020126A0 (fi) * | 2002-01-23 | 2002-01-23 | Orion Corp | Koostumuksia pulmonaaliseen antoon |
SE0200312D0 (sv) | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
JP4744876B2 (ja) * | 2002-08-21 | 2011-08-10 | ノートン・ヘルスケアー リミテッド | 乾燥粉末吸入組成物の製造方法 |
GB0219511D0 (en) | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
GB0219512D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Inhalation compositions with high drug ratios |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
US20050207983A1 (en) | 2004-03-05 | 2005-09-22 | Pulmatrix, Inc. | Formulations decreasing particle exhalation |
US20070098644A1 (en) * | 2005-10-31 | 2007-05-03 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
EP2425820B1 (en) | 2007-02-11 | 2015-04-08 | MAP Pharmaceuticals Inc | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
KR20090121338A (ko) | 2007-02-19 | 2009-11-25 | 씨아이피엘에이 엘티디. | 두 개 이상의 기관지확장제 또는 기관지확장제와 코르티코스테로이드의 약제학적 조합 |
EP1982709A1 (en) | 2007-04-19 | 2008-10-22 | CHIESI FARMACEUTICI S.p.A. | Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma |
CA2763939A1 (en) | 2009-05-29 | 2010-12-02 | Pearl Therapeutics, Inc. | Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems |
PL2538922T3 (pl) * | 2010-02-25 | 2016-11-30 | Formułowanie kompozycji do leczenia stanów zapalnych | |
EP2593108A2 (en) * | 2010-07-16 | 2013-05-22 | Cilpa Limited | Pharmaceutical compositions comprising r(+) budesonide and one or more bronchodilators |
AU2011296343B2 (en) | 2010-08-30 | 2015-12-10 | Pulmatrix Operating Company, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
US8758824B2 (en) | 2010-08-30 | 2014-06-24 | Pulmatrix, Inc. | Respirably dry powder comprising calcium lactate, sodium chloride and leucine |
CN102416179B (zh) * | 2010-09-28 | 2014-05-07 | 益得生物科技股份有限公司 | 用于哮喘的吸入性复方组合物 |
ES2899621T3 (es) | 2010-09-29 | 2022-03-14 | Pulmatrix Operating Co Inc | Polvos secos catiónicos que comprenden sal de magnesio |
RU2017144619A (ru) | 2010-09-29 | 2019-02-20 | Пулмэтрикс, Инк. | Катионы одновалентных металлов сухих порошков для ингаляций |
JOP20120023B1 (ar) * | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
WO2013130767A1 (en) | 2012-02-29 | 2013-09-06 | Pulmatrix, Inc. | Inhalable dry powders |
RU2504382C1 (ru) * | 2012-06-13 | 2014-01-20 | Шолекс Девелопмент Гмбх | Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения |
AU2014248455B2 (en) | 2013-04-01 | 2018-12-06 | Pulmatrix Operating Company, Inc. | Tiotropium dry powders |
ITMI20130571A1 (it) | 2013-04-10 | 2014-10-11 | Zambon Spa | Composizione farmaceutica contenente budesonide e formoterolo |
GB201408387D0 (en) * | 2014-05-12 | 2014-06-25 | Teva Pharmaceuticals Europ B V | Treatment of respiratory disorders |
WO2017108917A1 (en) * | 2015-12-22 | 2017-06-29 | Astrazeneca Ab | Pharmaceutical compositions for use in the treatment of chronic obstructive pulmonary disease |
IT202000006442A1 (it) * | 2020-03-27 | 2021-09-27 | Genetic S P A | Budesonide 21-phosphate salts and pharmaceutical compositions containing the same |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4203401A (en) | 1979-01-29 | 1980-05-20 | General Motors Corporation | Evaporative emissions canister |
IL95590A (en) | 1989-09-08 | 1996-06-18 | Glaxo Group Ltd | Medicinal preparations containing Salmetrol and Pluticasone Propionate |
JP3042866B2 (ja) | 1989-09-08 | 2000-05-22 | グラクソ・グループ・リミテッド | 呼吸疾患治療薬 |
US5250286A (en) * | 1990-05-07 | 1993-10-05 | Aegis Technology, Inc. | Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline |
PL164294B1 (pl) | 1990-12-20 | 1994-07-29 | Inst Farmaceutyczny | Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL |
US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
US5119791A (en) | 1991-06-07 | 1992-06-09 | General Motors Corporation | Vapor storage canister with liquid trap |
US5444521A (en) | 1991-07-15 | 1995-08-22 | Canon Kabushiki Kaisha | Image fixing device capable of controlling heating overshoot |
CA2356145A1 (en) * | 1991-12-18 | 1993-06-24 | Aktiebolaget Astra | New combination of formoterol and budesonide |
EP0613371B1 (en) | 1991-12-18 | 2002-03-06 | AstraZeneca AB | New combination of formoterol and budesonide |
US5408977A (en) | 1993-08-23 | 1995-04-25 | Walbro Corporation | Fuel tank with carbon canister and shut-off valve |
HU222355B1 (hu) | 1993-10-01 | 2003-06-28 | Astra Aktiebolag | Eljárás és berendezés finom gyógyszerhatóanyag-porok kezelésére és feldolgozására |
SE9404080L (sv) * | 1993-12-28 | 1995-06-29 | Ciba Geigy Ag | Förfarande för framställning av en optiskt ren enantiomer av formoterol |
US5511957A (en) | 1994-09-27 | 1996-04-30 | Walbro Corporation | High capacity fuel pump and filter combination |
US5983956A (en) * | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
SE9700134D0 (sv) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
GB9519692D0 (en) * | 1995-09-27 | 1995-11-29 | Quillin Helen | Atomising nozzle |
CN1207730A (zh) | 1995-11-24 | 1999-02-10 | 史密丝克莱恩比彻姆股份公司 | 喹啉衍生物 |
US5651349A (en) | 1995-12-11 | 1997-07-29 | Chrysler Corporation | Purge system flow monitor and method |
SE9603669D0 (sv) | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
TR199903272T2 (tr) | 1997-06-27 | 2000-08-21 | Astra Aktiebolag | Astim karsiti ilaçlarin yeni bilesimleri. |
SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
US5957114A (en) | 1998-07-17 | 1999-09-28 | Ford Motor Company | Evaporative emission canister for an automotive vehicle |
US5924410A (en) | 1998-07-20 | 1999-07-20 | Ford Motor Company | Evaporative emission canister for an automotive vehicle |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6004537A (en) | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
US6227862B1 (en) * | 1999-02-12 | 2001-05-08 | Advanced Drivers Education Products And Training, Inc. | Driver training system |
DE60016990T2 (de) | 1999-02-26 | 2005-12-29 | Walbro Corp., Cass City | Fahrzeugbrennstoffsystem |
SE9900834D0 (sv) | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
US6237574B1 (en) | 1999-04-20 | 2001-05-29 | Ford Motor Company | Evaporative emission canister for an automotive vehicle |
US6136075A (en) | 1999-05-03 | 2000-10-24 | Westvaco Corporation | Automotive evaporative emissions canister adsorptive restraint system |
JP3646217B2 (ja) | 1999-07-08 | 2005-05-11 | 愛三工業株式会社 | キャニスタモジュール |
US6374811B1 (en) | 2000-10-04 | 2002-04-23 | Ford Global Technologies, Inc. | System and method for minimizing fuel evaporative emissions from an internal combustion engine |
-
1998
- 1998-06-11 SE SE9802073A patent/SE9802073D0/xx unknown
-
1999
- 1999-05-28 AR ARP990102532A patent/AR018410A1/es unknown
- 1999-06-01 TW TW088109070A patent/TWI252756B/zh not_active IP Right Cessation
- 1999-06-09 SA SA99200234A patent/SA99200234B1/ar unknown
- 1999-06-09 MY MYPI99002351A patent/MY129281A/en unknown
- 1999-06-10 JP JP2000553082A patent/JP2002517450A/ja active Pending
- 1999-06-10 CZ CZ20004593A patent/CZ300874B6/cs not_active IP Right Cessation
- 1999-06-10 CA CA002334411A patent/CA2334411C/en not_active Expired - Lifetime
- 1999-06-10 TR TR2000/03666T patent/TR200003666T2/tr unknown
- 1999-06-10 IL IL13992199A patent/IL139921A0/xx active IP Right Grant
- 1999-06-10 US US09/367,950 patent/US20010049396A1/en not_active Abandoned
- 1999-06-10 CN CNB998072303A patent/CN100389771C/zh not_active Expired - Lifetime
- 1999-06-10 KR KR1020007013993A patent/KR20010052721A/ko not_active Application Discontinuation
- 1999-06-10 SK SK1888-2000A patent/SK286252B6/sk not_active IP Right Cessation
- 1999-06-10 DE DE69938390T patent/DE69938390T2/de not_active Expired - Lifetime
- 1999-06-10 WO PCT/SE1999/001031 patent/WO1999064014A1/en not_active Application Discontinuation
- 1999-06-10 AT AT99930103T patent/ATE389409T1/de active
- 1999-06-10 EP EP03002381A patent/EP1316311A1/en not_active Withdrawn
- 1999-06-10 RU RU2000131218/14A patent/RU2222332C2/ru not_active IP Right Cessation
- 1999-06-10 NZ NZ536279A patent/NZ536279A/en not_active IP Right Cessation
- 1999-06-10 HU HU0103108A patent/HUP0103108A3/hu unknown
- 1999-06-10 EE EEP200000740A patent/EE05661B1/xx unknown
- 1999-06-10 DK DK99930103T patent/DK1085877T3/da active
- 1999-06-10 BR BR9911073-3A patent/BR9911073A/pt not_active Application Discontinuation
- 1999-06-10 ID IDW20002566A patent/ID27937A/id unknown
- 1999-06-10 AU AU46710/99A patent/AU771715B2/en not_active Expired
- 1999-06-10 EP EP99930103A patent/EP1085877B1/en not_active Revoked
- 1999-06-10 UA UA2000126983A patent/UA87956C2/uk unknown
- 1999-06-10 PT PT99930103T patent/PT1085877E/pt unknown
- 1999-06-10 PL PL99344665A patent/PL344665A1/xx unknown
- 1999-06-10 EP EP10178172A patent/EP2266574A1/en not_active Withdrawn
- 1999-06-10 ES ES99930103T patent/ES2302384T3/es not_active Expired - Lifetime
-
2000
- 2000-11-27 ZA ZA200006943A patent/ZA200006943B/en unknown
- 2000-11-27 IL IL139921A patent/IL139921A/en not_active IP Right Cessation
- 2000-12-05 IS IS5752A patent/IS5752A/is unknown
- 2000-12-08 NO NO20006253A patent/NO20006253L/no not_active Application Discontinuation
-
2001
- 2001-08-17 HK HK01105814A patent/HK1035145A1/xx not_active IP Right Cessation
-
2003
- 2003-09-19 US US10/665,240 patent/US9295644B2/en not_active Expired - Lifetime
-
2008
- 2008-05-13 CY CY20081100507T patent/CY1110376T1/el unknown
-
2013
- 2013-02-18 NO NO20130269A patent/NO20130269L/no not_active Application Discontinuation
-
2014
- 2014-06-27 NO NO20140823A patent/NO20140823L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200003666T2 (tr) | Akut bir astım vakasının önlenmesi , tedavisi için formoterol | |
AU3912493A (en) | A pharmaceutical composition containing a defined lipid system | |
CA2258920A1 (en) | Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies | |
BG106030A (en) | Pharmaceutical composition | |
BR0207930A (pt) | Composições farmacêuticas lìquidas com sabor mascarado | |
BR0013704A (pt) | Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares | |
NZ295211A (en) | Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids | |
WO1999043354A3 (en) | Method for treating painful conditions of the anal region and compositions therefor | |
BR0014355A (pt) | Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva | |
CA2284774A1 (en) | Theobromine antitussive compositions | |
EP1048297A3 (en) | Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation | |
WO2002026191A3 (en) | Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue | |
IL136101A0 (en) | Pharmaceutical compositions containing azelaic acid | |
WO2000072835A3 (en) | Topical application of muscarinic and opioid agents for treatment of tinnitus | |
PT1058544E (pt) | Inibicao da actividade do tnf | |
ATE238034T1 (de) | Geschmacksmaskierung schlecht schmeckender formulierungen | |
MD980129A (en) | Antiherpetic remedy | |
AU2502301A (en) | Medicament and combination of compatible medicaments | |
EP0992242A4 (en) | PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS | |
EP1676832A3 (en) | Compounds and compositions for delivering active agents | |
ZA9711336B (en) | Sulfonamido or carboamido derivatives and pharmaceutical composition containing them as an active ingredient. | |
TH57976B (th) | ส่วนประกอบอีพลีรีโนน | |
CA2216700A1 (en) | Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide | |
DE69838981D1 (de) | Komponente und Zusammensetzungen zur Verabreichung von Wirkstoffen | |
MY128958A (en) | New oral formulation for 5-ht4 agonists or antagonists. |